GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

GRNQ · Dec 31, 2025

Greenpro Capital Corp.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001493152-26-013446General Corporate
Capex intensity67thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.13% · OPTIONAL · VALID

Operating cash generation35thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-86.34% · OPTIONAL · VALID

Revenue growth15thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

-40.69% · CORE · VALID

Gross margin45thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

80.35% · CORE · VALID

Operating margin35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

-103.80% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History30 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Increased
Previous
-103.73%
Current
-86.34%
Delta
17.39%
Growth Decreased
Previous
-27.14%
Current
-40.69%
Delta
-13.56%
Margin Increased
Previous
67.15%
Current
80.35%
Delta
13.20%
Profitability Increased
Previous
-132.38%
Current
-103.80%
Delta
28.58%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.